Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Xencor Inc (NQ: XNCR )

19.35 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 19.35
Bid (Size) 19.27 (10)
Ask (Size) 19.87 (10)
Prev. Close 19.35
Today's Range 19.35 - 19.35
52wk Range 16.49 - 26.84
Shares Outstanding 59,924,016
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Peeling Back The Layers: Exploring Xencor Through Analyst Insights
Via Benzinga
Xencor Regains CD20 x CD3 Bispecific T-Cell Engager
From Xencor, Inc.
Via Business Wire

Performance

YTD
-14.04%
-14.04%
1 Month
-17.31%
-17.31%
3 Month
-10.13%
-10.13%
6 Month
-8.73%
-8.73%
1 Year
-21.88%
-21.88%

More News

Read More
Decoding 6 Analyst Evaluations For Xencor
Via Benzinga
XNCR Stock Earnings: Xencor Misses EPS, Misses Revenue for Q1 2024
Via InvestorPlace
Xencor Reports First Quarter 2024 Financial Results
From Xencor, Inc.
Via Business Wire
Analyst Scoreboard: 6 Ratings For Xencor
Via Benzinga
Unveiling 4 Analyst Insights On Xencor
Via Benzinga
Recap: Xencor Q4 Earnings
Via Benzinga
Xencor Appoints Bart Cornelissen as Chief Financial Officer
From Xencor, Inc.
Via Business Wire
Xencor to Present at Upcoming Investor Conferences
From Xencor, Inc.
Via Business Wire
Xencor Reports Fourth Quarter and Full Year 2023 Financial Results
From Xencor, Inc.
Via Business Wire
Earnings Scheduled For February 27, 2024
Via Benzinga
Earnings Preview: Xencor
Via Benzinga
Navigating 4 Analyst Ratings For Xencor
Via Benzinga
Preview: Xencor's Earnings
Via Benzinga
Xencor to Host Webcast to Review Fourth Quarter and Full Year 2023 Financial Results and Provide Vudalimab Clinical Update
From Xencor, Inc.
Via Business Wire
Xencor to Present at the 42nd Annual J.P. Morgan Healthcare Conference
From Xencor, Inc.
Via Business Wire
Dane Leone Joins Xencor as Senior Vice President, Corporate Strategy
From Xencor, Inc.
Via Business Wire
Xencor Reports Third Quarter 2023 Financial Results
From Xencor, Inc.
Via Business Wire
Xencor Sells Portion of Royalties and Milestones from Ultomiris® and Monjuvi® to OMERS Life Sciences for $215 Million
From Xencor, Inc.
Via Business Wire
Xencor Presents Preclinical Data from Multiple XmAb® Research Programs at the SITC Annual Meeting
From Xencor, Inc.
Via Business Wire
Xencor to Host Third Quarter 2023 Financial Results Webcast and Conference Call on November 7, 2023
From Xencor, Inc.
Via Business Wire
Xencor Announces Planned Retirement of Chief Financial Officer John Kuch
From Xencor, Inc.
Via Business Wire
Earnings Scheduled For November 7, 2023
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.